GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
W

Wellnex Life WNX.AX · AUD

Consumer Staples · ASX · 🇦🇺 Australia

Compare

0.06

0.00%

Close of 9 Nov 2026, in AUD

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

About Wellnex Life

Its shares trade on ASX under the ticker WNX.AX. It has been listed since 15 March 2017. In the fiscal year to 30 June 2025, it reported revenue of A$23.6m and a net loss of A$15.6m. At that date it held total assets of A$28.1m and shareholders' equity of A$11.2m.

Wellnex Life Ltd. engages in the provision of health and wellness products. The company is headquartered in Melbourne, Victoria. The company went IPO on 2017-03-15. The firm is engaged in distributing consumer focused health and wellness products. The Company’s health and wellness products include vitamin and dietary supplements. Its brands include Little Inn Secrets, Performance Inspired, The Iron Company, Uganic, Wakey Wakey, Wagner Health Liquigesic, Australian Garlic, Bin Buddy, Bird HealthCare, Compeed, EllaOne, Koena, PlumRose, Simply7, SolarCare B3, Voost, and others. The Company, through a joint venture with Onelife Botanicals, is engaged in manufacturing, distribution and sale of cannabis and hemp-based products. Through Onelife Botanicals, it owns Medipharm’s Australian facility, specialized licensing and operational expertise, and a customer base in Australia and New Zealand.

Figures and description from our data supplier, not checked against the company's own report.

Company facts

Sector
Consumer Staples
Industry
Food Products
Listed since
15 Mar 2017

Leadership

Pay as last reported

  • Mr. Arash VesaliInterim Executive Chairman of the Board, since 2025
  • Mr. Zlatko BozinovskiChief Executive Officer, Managing Director, Executive Director, since 2021A$556,993
  • Ms. Yuan ZhangChief Financial Officer, Executive Director
  • Mr. Zheng LiCompany Secretary, since 2019A$195,364
  • Mr. John McgirrNon-Executive Director
  • Mr. Chien-Hong YehNon-Executive DirectorA$20,000
  • Mr. Hua Jian JiangIndependent Non-Executive DirectorA$104,205

Environmental, social and governance

Scores out of 100, from our data supplier

ESG
Overall
0
Environment
0
Social
0
Governance
0

SWOT analysis

AI-generated by our data supplier. Not written or checked by our editors.

AI-generated

Strengths

  • The company distributes a wide range of health and wellness brands.
  • It operates a joint venture for manufacturing cannabis and hemp products.
  • Medipharm's Australian facility provides specialized operational expertise.

Weaknesses

  • The firm relies on a joint venture for its cannabis operations.
  • Many listed brands may have limited market recognition.
  • Consumer staples sector faces intense competitive pressure.

Opportunities

  • Expanding the customer base in Australia and New Zealand.
  • Leveraging specialized licensing for hemp-based product sales.
  • Growing demand for dietary supplements and health products.

Threats

  • Regulatory changes could impact cannabis and hemp manufacturing.
  • Competitors may offer similar vitamin and supplement products.
  • Economic shifts might reduce consumer spending on wellness items.

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.